Parallel Advisors, LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 260 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$384
-37.3%
460.0%0.00%
Q2 2023$612
+14.8%
460.0%0.00%
Q1 2023$533
+41.8%
460.0%0.00%
Q4 2022$376460.0%0.00%
Q3 2022$0460.0%0.00%
Q2 2022$0
-100.0%
46
-22.0%
0.00%
Q1 2022$1,000
-50.0%
59
-42.7%
0.00%
Q4 2021$2,000103
+635.7%
0.00%
Q3 2021$0
-100.0%
14
-58.8%
0.00%
Q2 2021$1,00034
+277.8%
0.00%
Q1 2021$0
-100.0%
9
-98.7%
0.00%
Q3 2020$7,000
+133.3%
712
-27.2%
0.00%
Q2 2020$3,000
+200.0%
978
+83.8%
0.00%
Q1 2020$1,000
-98.2%
532
-95.0%
0.00%
-100.0%
Q4 2019$55,000
+205.6%
10,640
+201.5%
0.00%
+100.0%
Q3 2019$18,000
+50.0%
3,529
+73.8%
0.00%
+100.0%
Q2 2019$12,000
+200.0%
2,031
+281.8%
0.00%
Q1 2019$4,000
+33.3%
5320.0%0.00%
Q4 2018$3,0000.0%5320.0%0.00%
Q3 2018$3,000
+200.0%
5320.0%0.00%
Q2 2018$1,0000.0%5320.0%0.00%
Q1 2018$1,0005320.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,660,000$24,206,00011.49%
Data Collective II GP, LLC 164,249$1,495,0005.44%
Decheng Capital Management III (Cayman), LLC 1,463,872$13,321,0004.08%
SB Management Ltd 1,886,107$17,164,0003.33%
Casdin Capital, LLC 7,990,652$72,715,0003.26%
ORACLE INVESTMENT MANAGEMENT INC 1,225,395$11,151,0002.20%
Jackson Square Partners, LLC 22,542,589$205,137,0002.04%
BOURNE LENT ASSET MANAGEMENT INC 556,865$5,067,0001.59%
ARK Investment Management 27,259,521$248,062,0001.04%
Nikko Asset Management Americas, Inc. 14,021,205$127,873,0000.94%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders